Research is never a solitary journey.
I am deeply grateful to @Fondaz_Veronesi for the great support and trust provided over these years.
Their commitment to scientific research has played an pivotal role in allowing me to continue pursuing my work in Myeloma #mmsm
Per valorizzare il talento, la professionalità e la passione dei nostri ricercatori, dal 2018 Fondazione Veronesi ha istituito il “Fondazione Umberto Veronesi Award” per premiare le tre migliori ricerche di scienziati sostenuti da Fondazione e pubblicati… https://t.co/CT9017NJH1
The PANGEA-SMM model is out. A model based on dynamic trajectory to precisely predict risk of progression in smoldering myeloma. Thank you to our collaborators and patients all over the world who made this happen! #mmsm@NatureMedicine
MMBridge: esperti internazionali a confronto sul #MielomaMultiplo. Evento organizzato dai docenti e ricercatori di #PoliclinicoMi e de @LaStatale: Niccolò Bolli, Matteo Claudio Da Vià e Francesco Passamonti - direttore Ematologia dell'Ospedale
➡️https://t.co/xjiFr6Rprf
Two inspiring days of science and collaboration. Thanks to the outstanding faculty and all participants who contributed to the discussions on #myeloma and #mmsm at #MMBridge. Special thanks to @nickbolli for the all the great organization!
Thanks to everyone who took part in the MMBridge meeting. IInternational faculty and italian experts gathered for two days talking about #myeloma#mmsm. Kudos to @matteoclaudio84 for the organization and @policlinicoMI@LaStatale for the support
Thanks to everyone who took part in the MMBridge meeting. IInternational faculty and italian experts gathered for two days talking about #myeloma#mmsm. Kudos to @matteoclaudio84 for the organization and @policlinicoMI@LaStatale for the support
it's almost MMBridge time! for those of you who will be in Milan or around on the 12th and 13th of March, this meeting is packed with international experts and will be a great educational opportunity on #myeloma#mmsm
https://t.co/Ljgr3ALEqn
NRF1 orchestrates essential functions in MM by targeting gene promoters linked to ubiquitination and predicts poor outcome prognosis. Read the full article in Blood: https://t.co/RS7LpcRONl
The NDMM prognostic score from the IMS is out. How should we deal with it in daily practice, across laboratories with different expertises and resources? Within the European Myeloma Network we discuss this issue @Hemasphere_EHA#mmsm#MultipleMyeloma#RRMM
https://t.co/K1ceTSgTat
The quest for cure of myeloma starts from the understanding of its initiation and evolution. We contributed to a pivotal work led by @FrancescoMaura4 and @VincentRK
Genomics Define Malignant Transformation in Myeloma Precursor Conditions https://t.co/baofpEcqcx
Yeah! Now finally out in print. Thanks to all the friends and colleagues who collaborated to bring home this first in kind effort in #amyloidosis. @nickbolli, @MMoscvin, Ray Comenzo, JoaoPaulo @GygiLab and @KleinLabHMS
Inflamed pPCs have perturbed interactions with the TME leading to immunoparesis and correlate with decreased survival in MM. https://t.co/AawvdKv6bK #lymphoidneoplasia#multiplemyeloma
Inflamed pPCs have perturbed interactions with the TME leading to immunoparesis and correlate with decreased survival in MM. https://t.co/AawvdKv6bK #lymphoidneoplasia#multiplemyeloma